logo

For the Inventor, By the Inventor

Malvern, PA, United States of America

Marian T Nakada

This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignee: Centocor, Inc.. Active years: 2007-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marian T Nakada. Retrieved from https://idiyas.com/inventor/marian-t-nakada

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 50.0

Average Co-Inventor Count = 4.0

ph-index = 4

Forward Citations = 214(Granted Patents)


Company Filing History:

goldMedal4 out of 144 
 
Centocor, Inc.
 patents

Years Active: 2007-2011

Loading Chart...
4 patents (USPTO):Explore Patents
1. 8071729 - Anti-integrin antibodies, compositions, methods and uses (2011-12-06),
2. 8071333 - Anti-integrin antibodies, compositions, methods and uses (2011-12-06),
3. 7550142 - Anti-integrin antibodies, compositions, methods and uses (2009-06-23),
4. 7163681 - Anti-integrin antibodies, compositions, methods and uses (2007-01-16),

Title: The Innovations of Marian T Nakada

Introduction

Marian T Nakada is a notable inventor based in Malvern, PA (US). He has made significant contributions to the field of biotechnology, particularly in the development of anti-integrin antibodies. With a total of 4 patents to his name, Nakada's work has implications for therapeutic applications.

Latest Patents

His latest patents include groundbreaking inventions related to anti-integrin antibodies. The first patent focuses on novel anti-alpha-V subunit antibodies, which encompass isolated nucleic acids that encode these antibodies, as well as methods for their use in therapeutic compositions. The second patent similarly addresses anti-alpha-V subunit antibodies, detailing their applications in various therapeutic methods and devices.

Career Highlights

Marian T Nakada is currently associated with Centocor, Inc., a company known for its innovative approaches in the pharmaceutical industry. His work at Centocor has allowed him to explore and develop new therapeutic strategies that leverage the potential of anti-integrin antibodies.

Collaborations

Throughout his career, Nakada has collaborated with esteemed colleagues, including Jill M Giles-Komar and Linda Snyder. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Marian T Nakada's contributions to the field of biotechnology through his patents and work at Centocor, Inc. highlight his role as a significant inventor. His innovations in anti-integrin antibodies pave the way for future advancements in therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…